New device aims to simplify prostate cancer diagnosis
NCT ID NCT05362032
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tests whether a new device called the OmnEcoil system can safely and effectively combine two separate procedures—MRI imaging and biopsy—into one session for diagnosing prostate cancer. The device uses a special coil placed in the rectum to take high-quality images and guide the biopsy at the same time. The trial involves 45 men aged 45 and older with elevated PSA levels or abnormal exams, and it will check if the device can successfully collect tissue samples without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.